|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||||||||||||
  AnaesthesiaVolume 47 Issue 8, Pages 672 - 677 Published Online: 22 Feb 2007 Journal compilation © 2010 The Association of Anaesthetists of Great Britain and Ireland Journal of the Association of Anaesthetists of Great Britain and Ireland
Abstract | References | Full Text: PDF (Size: 498K) | Related Articles | Citation Tracking  A multiple dose comparison of combinations of ibuprofen and codeine and paracetamol, codeine and caffeine after third molar surgery Copyright 1992 The Association of Anaesthetists of Great Britain and Ireland KEYWORDS
Analgesics
• codeine • ibuprofen • paracetamol •
Pain
• postoperative •
Surgery
• dental ABSTRACT
In a randomised, double-blind, double-dummy, multiple dose, crossover study in 30 patients we compared an ibuprofen/codeine combination (400 mg ibuprofen/25.6 mg codeine phosphate) with a paracetamol/codeine/caffeine combination (1 g paracetamol/ 16 mg codeine phosphate/60 mg caffeine) for pain relief over 6 days after two-stage bilateral lower third molar removal. The ibuprofen combination produced significantly greater analgesia than the paracetamol combination, both on single-dose analysis of the first and second days and on multiple-dose measures for days 1, 2, 3 and 4. The mean incidence of adverse effects over the 6 days was 20% for both combinations. This trial design (crossover with multiple dosing in outpatients) is a sensitive way of testing for analgesia, and is potentially more predictive of adverse effect problems than single-dose studies. It confirms that multiple dosing may show increased efficacy. Accepted 8 January 1992 | 
|
